Sinonasal Adenocarcinoma
How We Can Help You
Sinonasal adenocarcinomas are rare cancerous tumors of the salivary glands and sinus cavity.
Stanford is a global referral center for the diagnosis and surgical treatment of sinonasal adenocarcinoma, using the endoscopic endonasal approach to surgery. That is a scarless surgery that uses the nostril as a natural pathway to the tumor.
WHAT WE OFFER YOU FOR SINONASAL ADENOCARCINOMA
- Globally-recognized expertise in the diagnosis and treatment of sinonasal adenocarcinoma
- Team-based treatment planning that brings together specialists from neurosurgery, head and neck surgery, neuroradiology, radiation oncology, neuropathology, and more.
- Advanced treatment options usually begin with scarless endoscopic surgery through the nostril and follow with radiation therapy,
- Comprehensive support services like nutritional and emotional support to help you with your specific symptoms and the challenges of this experience.
- An active clinical research program dedicated to broadening options for the diagnosis and treatment of sinonasal adenocarcinomas.
- Assistance from our International Medical Services team to plan your travel and accommodations.
Treatment Options for Sinonasal Adenocarcinoma
Sinonasal adenocarcinomas are rare cancers, so treatment at a high-volume academic medical center by highly specialized head and neck and skull base surgeons and radiation oncologists is important for the best outcomes.
Our team of neurosurgeons, head and neck surgeons, radiation oncologists and other specialists work together to develop an individualized treatment plan for your needs.
Surgery
Radiation Therapy
For patients with small tumors that are contained in the salivary gland or sinus cavity, the primary treatment endoscopic endonasal surgery, which scarless surgery that accesses the tumor through the nostril. For large tumors, your surgeon may combine endoscopic endonasal surgery with craniotomy. The goal is to remove the tumor with a rim of normal tissue around it.
Radiation therapy may be recommended after surgery if the tumor is thought to be aggressive or if it was impossible to fully remove.
Radiation therapy usually begins about 4-6 weeks after surgery with a dose every Monday through Friday for about 6 weeks.
If the location or extent of the tumor make surgery impossible, then a radiation-based approach can be used (but is not as effective).
For patients with small tumors that are contained in the salivary gland or sinus cavity, the primary treatment endoscopic endonasal surgery, which scarless surgery that accesses the tumor through the nostril. For large tumors, your surgeon may combine endoscopic endonasal surgery with craniotomy. The goal is to remove the tumor with a rim of normal tissue around it.
close Surgery
Radiation therapy may be recommended after surgery if the tumor is thought to be aggressive or if it was impossible to fully remove.
Radiation therapy usually begins about 4-6 weeks after surgery with a dose every Monday through Friday for about 6 weeks.
If the location or extent of the tumor make surgery impossible, then a radiation-based approach can be used (but is not as effective).
close Radiation Therapy
Clinical Trials for Adenocarcinoma
Clinical trials evaluate new approaches, devices, or medications in the treatment of adenocarcinomas. Ask your doctor or clinical trials coordinator about available trials that may be additional options for your care.
To learn more about the clinical trials we offer, contact Maria Coburn at 650-736-9551.
What are Sinonasal Adenocarcinomas?
Our Clinics
To schedule an appointment, please call: 650-497-7777
Sinonasal Adenocarcinoma
Sinonasal adenocarcinomas are rare cancerous tumors of the salivary glands and sinus cavity.
Stanford is a global referral center for the diagnosis and surgical treatment of sinonasal adenocarcinoma, using the endoscopic endonasal approach to surgery. That is a scarless surgery that uses the nostril as a natural pathway to the tumor.